Delivery Order SPE2DB20D1100-SPE2DB25FE5G1
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,549.14 to AmerisourceBergen Drug Corp for the supply of Neupogen 300 mcg/ml vials. The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's broader...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Neupogen 300 mcg/mL vials with a ceiling value of $2,429.58. This is a firm fixed price, competitive delivery order with no set-aside designation and a completion date of July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,934.37 to AmerisourceBergen Drug Corp for the supply of Neupogen 480 mcg/1.6 mL vials on July 28, 2025. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, with performance to be executed from the contractor's Conshohocken, Pennsylvania facility. The contract includes no set-aside designation, indicating it was awarded through open competition. Neupogen (filgrastim) is a critical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Neupogen 480 mcg/0.8 mL syringes. The contract is a firm-fixed-price delivery order with a ceiling value of $4,019.12 and a performance period through June 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive global...
- This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the NEUPOGEN 300 MCG/ML VIALML product, with a firm fixed price and an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NEUPOGEN 300 MCG/ML VIALML pharmaceutical products. The contract, valued at $8,527.28, was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 15, 2024 with a completion date of April 16, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen, a major pharmaceutical...
- This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of the medication NEUPOGEN 300 MCG/ML VIALML, with an ultimate completion date of April 17, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of NEUPOGEN 300 MCG/0.5 ML SYR 0.5ML to the Defense Logistics Agency (DLA). The $3,522.48 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 15, 2023 and was awarded on May 12, 2023. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $7,438.72 to AmerisourceBergen Drug Corp for Neulasta 6 mg/0.6 ml syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GONAL-F RFF Redi-Ject 900 Unit 1.44ML pharmaceutical product with a ceiling value of $33,834.30. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract was competitively awarded without set-aside provisions, reflecting...